Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 11, 2019 - Issue
Submit an article Journal homepage
135
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Value For Money In The Treatment Of Patients With Type 2 Diabetes Mellitus: Assessing The Long-Term Cost-Effectiveness Of IDegLira Versus iGlarLixi In Italy

Johannes Pöhlmann1 Health Economics, Ossian Health Economics and Communications, Basel4051, Switzerland
,
Roberta Montagnoli2 External Affairs-Region Europe, Novo Nordisk SpA, RomeIT00144, Italy
,
Giusi Lastoria3 Medical Advice, Novo Nordisk SpA, RomeIT00144, ItalyORCID Iconhttps://orcid.org/0000-0002-2276-447X
ORCID Icon,
Witesh Parekh4 European HEOR, Nova Nordisk Ltd, West SussexRH6 0PA, UK
,
Marie Markert5 Global Market Access, Novo Nordisk A/S, SøborgDK-2860, Denmark
&
Barnaby Hunt1 Health Economics, Ossian Health Economics and Communications, Basel4051, SwitzerlandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5420-279X
ORCID Icon
Pages 605-614 | Published online: 07 Oct 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.